Viewing Study NCT05817903


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2026-01-04 @ 2:25 PM
Study NCT ID: NCT05817903
Status: RECRUITING
Last Update Posted: 2023-05-08
First Post: 2023-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients
Sponsor: Consorzio Oncotech
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mRCC View